Adapalene and Doxorubicin Synergistically Promote Apoptosis of TNBC Cells by Hyperactivation of the ERK1/2 Pathway Through ROS Induction

Doxorubicin is a commonly used chemotherapeutic agent to treat several malignancies, including aggressive tumors like triple-negative breast cancer. It has a limited therapeutic index owing to its extreme toxicity and the emergence of drug resistance. As a result, there is a pressing need to find in...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehraj, Umar, Mir, Irfan Ahmad, Hussain, Mahboob ul, Alkhanani, Mustfa, Wani, Nissar Ahmad, Mir, Manzoor Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298514/
https://www.ncbi.nlm.nih.gov/pubmed/35875119
http://dx.doi.org/10.3389/fonc.2022.938052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298514/
https://www.ncbi.nlm.nih.gov/pubmed/35875119
http://dx.doi.org/10.3389/fonc.2022.938052

Ejemplares similares